Phil Galewitz

Visit kff.org to read Phil's bio.

pgalewitz@kff.org
@philgalewitz

Hospitals, Insurers Invest Big Dollars to Tackle Patients’ Social Needs

Eager to control costs, health systems and insurers are trying to address patients’ social needs such as food insecurity, transportation and housing. Yet, after years of testing, there’s slim evidence these efforts pay off.

Pandemia eleva el número de beneficiarios de Medicaid a más de 80 millones

Las últimas cifras de inscripción al Medicaid muestran que creció de 71,3 millones de miembros en febrero de 2020, cuando la pandemia comenzaba en los Estados Unidos, a 80,5 millones en enero, según un análisis de KFF de datos federales.

Biden Administration Signals It’s in No Rush to Allow Canadian Drug Imports

Federal officials asked a court to dismiss a suit by drugmakers over the policy enacted by the Trump administration that would allow states to bring in cheaper prescription medications from Canada. The filing said the lawsuit was moot because it’s unclear when or if the FDA would approve any state’s importation plan.

‘Painless’ Glucose Monitors Pushed Despite Little Evidence They Help Most Diabetes Patients

The numbers of people wearing these monitors are soaring as prices have fallen and device-makers promote them to doctors and patients. But few studies show the devices lead to better outcomes for the nearly 25 million Americans with Type 2 diabetes who don’t inject insulin to regulate their blood sugar.